Literature DB >> 16814896

Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration.

Tatsuya Okuda1, Shigeru Kawakami, Tadahiro Maeie, Takuro Niidome, Fumiyoshi Yamashita, Mitsuru Hashida.   

Abstract

In this study, we synthesized dendritic poly(L-lysine)s (DPKs), dendritic poly(L-ornithine)s (DPOs), which are constructed as novel amino acid dendrimers, and PEGylated KG6 (the sixth generation of DPKs), and evaluated the physicochemical properties and biodistribution characteristics of these dendrimers. The particle size of DPKs and DPOs was well controlled in the nanometer range. The zeta-potential of these dendrimers was slightly positive and this gradually increased in association with their generation. After intravenous administration to mice, all tested dendrimers cleared rapidly from blood flow and mainly accumulated in the liver and kidney. The hepatic and renal accumulation changed in a generation-dependent manner. In contrast, no significant distributional differences between same generation of DPK and DPO were observed, although the constituent amino acids, particle size, and zeta-potential were different. However, PEGylation of KG6 caused great changes in particle size, zeta-potential, blood retention and organ distribution in vivo, indicating that the PEGylation is applicable strategy to improve biodistribution characteristics of dendrimeric molecules. The information provided by this study will be helpful for the development of future drug delivery systems using amino acid dendrimers as safe drug carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814896     DOI: 10.1016/j.jconrel.2006.05.009

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

Review 1.  Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.

Authors:  Wassana Wijagkanalan; Shigeru Kawakami; Mitsuru Hashida
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Molecular dynamics simulation of coarse-grained poly(L-lysine) dendrimers.

Authors:  Ali Rahimi; Sepideh Amjad-Iranagh; Hamid Modarress
Journal:  J Mol Model       Date:  2016-02-17       Impact factor: 1.810

3.  Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.

Authors:  Analette I Lopez; Rose Y Reins; Alison M McDermott; Barbara W Trautner; Chengzhi Cai
Journal:  Mol Biosyst       Date:  2009-07-03

4.  Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats.

Authors:  Karol Ciepluch; Barbara Ziemba; Anna Janaszewska; Dietmar Appelhans; Barbara Klajnert; Maria Bryszewska; Wiesława Agnieszka Fogel
Journal:  J Physiol Biochem       Date:  2012-02-28       Impact factor: 4.158

Review 5.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

Authors:  S Sadekar; H Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2011-09-29       Impact factor: 15.470

6.  Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Bing Wang; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

7.  Recent advances in targeted drug delivery approaches using dendritic polymers.

Authors:  Jason Bugno; Hao-jui Hsu; Seungpyo Hong
Journal:  Biomater Sci       Date:  2014-12-11       Impact factor: 6.843

8.  Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.

Authors:  Deborah M Sweet; Rohit B Kolhatkar; Abhijit Ray; Peter Swaan; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2009-04-22       Impact factor: 9.776

9.  Genome-free viral capsids as carriers for positron emission tomography radiolabels.

Authors:  Jacob M Hooker; James P O'Neil; Dante W Romanini; Scott E Taylor; Matthew B Francis
Journal:  Mol Imaging Biol       Date:  2008-04-25       Impact factor: 3.488

10.  Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.

Authors:  Megan E Fox; Steve Guillaudeu; Jean M J Fréchet; Katherine Jerger; Nichole Macaraeg; Francis C Szoka
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.